Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

著者: Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
出版事項 2012

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma

著者: Davidson, Ben, McFadden, Erin, Holth, Arild, Brunetti, Marta, Flørenes, Vivi Ann
出版年 Virchows Arch (2020)

Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma

著者: Flørenes, Vivi Ann, Emilsen, Elisabeth, Dong, Hiep Phuc, Førsund, Mette, Holm, Ruth, Slipicevic, Ana
出版年 Cancer Med (2015)

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes

著者: Wang, Zhihui, Trope, Claes G, Flørenes, Vivi Ann, Suo, Zhenhe, Nesland, Jahn M, Holm, Ruth
出版事項 2010

Collateral Expression of Proangiogenic and Tumorigenic Properties in Intestinal Epithelial Cell Variants Selected for Resistance to Anoikis

著者: Rak, Janusz, Mitsuhashi, Yoshihiro, Sheehan, Cap, Krestow, Julia K, Florenes, Vivi Ann, Filmus, Jorge, Kerbel, Robert S
出版事項 1999

Protein Expression of the Cell-Cycle Inhibitor p27(Kip1) in Malignant Melanoma : Inverse Correlation with Disease-Free Survival

著者: Flørenes, Vivi Ann, Mælandsmo, Gunhild M., Kerbel, Robert S., Slingerland, Joyce M., Nesland, Jahn M., Holm, Ruth
出版事項 1998

E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27(KIP1)

著者: St. Croix, Brad, Sheehan, Capucine, Rak, Janusz W., Flørenes, Vivi Ann, Slingerland, Joyce M., Kerbel, Robert S.
出版事項 1998

High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy

著者: Magnussen, Gry Irene, Holm, Ruth, Emilsen, Elisabeth, Rosnes, Anne Katrine Ree, Slipicevic, Ana, Flørenes, Vivi Ann
出版事項 2012

High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients

著者: Magnussen, Gry Irene, Hellesylt, Ellen, Nesland, Jahn M, Trope, Claes G, Flørenes, Vivi Ann, Holm, Ruth
出版事項 2013

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells

著者: Slipicevic, Ana, Jørgensen, Kjersti, Skrede, Martina, Rosnes, Anne Katrine Ree, Trøen, Gunhild, Davidson, Ben, Flørenes, Vivi Ann
出版事項 2008

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

著者: Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
出版年 Cell Death Discov (2016)

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

著者: Slipicevic, Ana, Holm, Ruth, Emilsen, Elisabeth, Ree Rosnes, Anne Katrine, Welch, Danny R, Mælandsmo, Gunhild M, Flørenes, Vivi Ann
出版事項 2012

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

著者: Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
出版年 BMC Cancer (2015)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

著者: Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
出版事項 2013

Soluble AXL as a marker of disease progression and survival in melanoma

著者: Flem-Karlsen, Karine, Nyakas, Marta, Farstad, Inger Nina, McFadden, Erin, Wernhoff, Patrik, Jacobsen, Kari Dolven, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
出版年 PLoS One (2020)

Candidate Genes for Testicular Cancer Evaluated by In Situ Protein Expression Analyses on Tissue Microarrays

著者: Skotheim, Rolf I, Abeler, Vera M, Nesland, Jahn M, Fosså, Sophie D, Holm, Ruth, Wagner, Urs, Flørenes, Vivi Ann, Aass, Nina, Kallioniemi, Olli P, Lothe, Ragnhild A
出版事項 2003

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy

著者: Dillard, Pierre, Köksal, Hakan, Maggadottir, Solrun Melkorka, Winge-Main, Anna, Pollmann, Sylvie, Menard, Mathilde, Myhre, Marit Renée, Mælandsmo, Gunhild M., Flørenes, Vivi Ann, Gaudernack, Gustav, Kvalheim, Gunnar, Wälchli, Sébastien, Inderberg, Else Marit
出版年 Mol Ther (2021)

MX2 is a novel regulator of cell cycle in melanoma cells

著者: Juraleviciute, Marina, Pozniak, Joanna, Nsengimana, Jérémie, Harland, Mark, Randerson-Moor, Juliette, Vernhoff, Patrik, Bassarova, Assia, Øy, Geir Frode, Trøen, Gunhild, Flørenes, Vivi Ann, Bishop, David Timothy, Herlyn, Meenhard, Newton-Bishop, Julia, Slipicevic, Ana
出版年 Pigment Cell Melanoma Res (2019)

Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

著者: Schaner, Marci E, Davidson, Ben, Skrede, Martina, Reich, Reuven, Flørenes, Vivi Ann, Risberg, Björn, Berner, Aasmund, Goldberg, Iris, Givant-Horwitz, Vered, Tropè, Claes G, Kristensen, Gunnar B, Nesland, Jahn M, Børresen-Dale, Anne-Lise
出版事項 2005

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases()

著者: Flørenes, Vivi Ann, Flem-Karlsen, Karine, McFadden, Erin, Bergheim, Inger Riise, Nygaard, Vigdis, Nygård, Vegard, Farstad, Inger Nina, Øy, Geir Frode, Emilsen, Elisabeth, Giller-Fleten, Karianne, Ree, Anne Hansen, Flatmark, Kjersti, Gullestad, Hans Petter, Hermann, Robert, Ryder, Truls, Wernhoff, Patrik, Mælandsmo, Gunhild Mari
出版年 Transl Oncol (2019)